Probiotics in inflamatory bowel disease
Open Access
- 1 May 2001
- Vol. 48 (5) , 609
- https://doi.org/10.1136/gut.48.5.609
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Probiotics and Inflammatory Bowel Disease: Is There a Scientific Rationale?Inflammatory Bowel Diseases, 2000
- V. Mechanisms of immunologic sensation of intestinal contentsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2000
- Immunity and probioticsImmunology Today, 1999
- Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trialThe Lancet, 1999
- Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative?Gastroenterology, 1999
- Lactobacillus species prevents colitis in interleukin 10 gene–deficient miceGastroenterology, 1999
- Double‐blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitisAlimentary Pharmacology & Therapeutics, 1997
- Enteric microflora in IBD: Pathogens or commensals?Inflammatory Bowel Diseases, 1997